Verily reposted this
💊Imagine if patients with chronic diseases such as diabetes received their medication in pill form rather than injecting needles to themselves every day? ✨ We are happy to announce the launch of Exolvo Biosciences, a collaboration between NLC Health Ventures and Verily, a company of Alphabet Inc./Google. By using next-generation oral administration technology, Exolvo Biosciences envisions a future in which they transform the landscape of drug delivery. With flexible capsule sizes and modular designs, Exolvo makes treatments more accessible and less invasive. Currently, Exolvo Biosciences is in the process of assembling an IND package in the US while actively engaging with key pharmaceutical and biotech partners. "There is a need for innovative solutions for people living with chronic diseases" says Exolvo co-founder and CEO Brian Longstreet. Curious to learn more about Exolvo’s technology? Read the article by European Biotechnology - Life Science and Industry Magazine (EBM) here: https://lnkd.in/dftKBE8Z Nick Ibery #DrugDelivery #ChronicDiseaseManagement #LifeSciences #OralMedication #Pharmaceuticals #Verily #HealthInnovation